Dietary factors and Alzheimer’s disease. Luchsinger JA, Mayeux R. The Lancet neurology, 2004. PMID:15380154
Diet and Alzheimer’s disease. Luchsinger JA1, Noble JM, Scarmeas N. Current neurology and neuroscience reports, 2007.PMID:17764625
Medications and diet: protective factors for AD? Claudia H. Kawas, Alzheimer disease & associated disorders, 2012. PMC3373253
Decline in Weight and Incident Mild Cognitive Impairment. Alhurani ER, Vassilaki M et al. JAMA neurology, 2016. DOI:10.1001/jamaneurol.2015.4756.
Магазаник Н. А., «Диагностика без анализов».
Ultrasound screening in pregnancy: a systematic review. Bricker L, Garcia J et al. Health Technology Assessment, 2000. PMID:11070816
Effectiveness versus efficacy of treatment of hypertension for stroke prevention. Whisnant JP. Neurology, 1996. PMID:8614485
Smoking and risk of stroke. Hankey GJ. Journal of cardiovascular risk, 1999. PMID:10501270
Smoking cessation and the risk of stroke in middle-aged men. Wannamethee SG, Shaper AG et al. JAMA, 1995. PMID:7596004
Obesity. Haslam WD, James TP. The Lancet, 2005. DOI:10.1016/S0140–6736(05)67483–1
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment. The Lancet, 1998. PMID:9742976
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study. Dormandy AJ, Charbonnel B et al. The Lancet, 2005. DOI:10.1016/S0140–6736(05)67528–9
Thrombolysis for acute ischaemic stroke. Wardlaw MJ, Murray V et al. Cochrane Stroke Group, 2014. PMC4153726
Global and regional burden of stroke during 1990–2010. Feigin LV, Forouzanfar HM et al. The Lancet, 2014. PMC4181600
Life After a Stroke. http://www.nhlbi.nih.gov/health/health-topics/topics/stroke/lifeafter
Stroke. Donnan AG, Fisher M et al. The Lancet, 2008. DOI:10.1016/S0140–6736(08)60694–7
Definition and evaluation of transient ischemic attack – AHA/ASA Scientific Statement. Stroke, 2009. DOI:10.1161/STROKEAHA.108.192218
Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial. Berge EP, Cohen G et al. The Lancet Neurology, 2016. DOI:10.1016/S1474–4422(16)30139–9
Meditation therapy for anxiety disorders. Krisanaprakornkit T, Sriraj W et al. Cochrane Common Mental Disorders Group, 2006. DOI:10.1002/14651858.CD004998.pub2
Д.А.Леонтьев «Экзистенциальная тревога и как с ней не бороться». Московский Психотерапевтический Журнал 2003, № 2
Tips to Manage Anxiety and Stress. https://www.adaa.org/tips-manage-anxiety-and-stress
Treatment of the depressive phase of bipolar affective disorder: a review. Muneer A. JPMA, 2013. PMID:23901682
Genetics of bipolar disorder. Berit Kerner. Journal of The Application of Clinical Genetics, 2014. PMC3966627
Characteristics and duration of mania: implications for continuation treatment. Steve Titmarsh. Progress in Neurology and Psychiatry, 2013. DOI:10.1002/pnp.283
Bipolar disorder and substance abuse. Robert M. Post and Peter Kalivas. The British Journal of Psychiatry, 2013. PMC4340700
Mood episodes and mood disorders. Beesdo K, Hofler M et al. Bipolar Disorders, 2009. DOI:10.1111/j.1399–5618.2009.00738.x
Psychosocial disability in the course of bipolar I and II disorders. Judd LL, Akiskal SH et al. JAMA psychiatry, 2005. DOI:10.1001/archpsyc.62.12.1322
Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Swann CA, Lafer B et al. The American journal of psychiatry, 2013. DOI:10.1176/appi.ajp.2012.12030301
Dysthymia and cyclothymia in psychiatric practice a century after Kraepelin. Akiskal HS. Journal of affective disorders, 2001. PMID:11172870
Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. Hirschfeld RM, Lewis L, Vornik LA. Journal of clinical psychiatry, 2003. PMID:12633125
Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania – a systematic review and meta-analysis. Tarr PG, Glue P, Hebrison P. Journal of affective disorders, 2011. DOI:10.1016/j.jad.2010.11.009
Биполярное расстройство. https://www.omh.ny.gov/omhweb/russian/booklets/bipolar.html
Information about bipolar disorders. http://www.psychosis-bipolar.com/
Bipolar disorder. Anderson IM, Haddad PM, Scott J. BMJ, 2012. PMID:23271744
The psychiatric comorbidities of cluster headache. Robbins MS. Current pain and headache reports, 2013. DOI:10.1007/s11916–012–0313–8
Cluster headache. Weaver-Agostoni J. American family physician, 2013. PMID:23939643
Diagnosis and management of the primary headache disorders in the emergency department setting. Friedman BW, Grosberg BM. Emergency Medicine Clinics of North America, 2009 PMC2676687
International Headache Society (IHS) classification ICHD-II. http://www.ihs-classification.org/en/02_klassifikation/02_teil1/03.01.00_cluster.html
What predicts evolution from episodic to chronic cluster headache? Torelli P, Manzoni GC. Current pain and headache reports. PMID:11749880
Lateralization in cluster headache: a Nordic multicenter study. Meyer EL, Laurell K et al. Journal of headache and pain. PMC3451747
The vascular theory of migraine – a great story wrecked by the facts. Peter J. Goadsby. Brain, 2008. DOI:10.1093/brain/awn321
Cluster headache: evidence for a disorder of circadian rhythm and hypothalamic function. Pringsheim T. Canadian Journal of Neurological Sciences, 2002. PMID:11858532
Features involved in the diagnostic delay of cluster headache. J A van Vliet, P Eekers et al. Journal of neurology, neurosurgery & psychiatry, 2003. PMC1738593
Management of cluster headache. Tfelt-Hansen PC, Jensen RH. CNS drugs, 2012. PMID:22650381
Diagnostic and therapeutic trajectory of cluster headache patients in Flanders. Van Alboom E, Louis P et al. Acta Neurologica Belgica, 2009. PMID:19402567
Response to intravenous lidocaine in a patient with SUNCT syndrome. Arroyo AM, Durán XR et al. Cephalalgia, 2010. PMID:19438923
Cluster headache @ MedlinePlus. https://medlineplus.gov/ency/article/000786.htm
EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. http://own.0x3.ru/index.php/s/MMMv64XWWIOjEM8
Guillain-Barré syndrome after exposure to influenza virus. Lehmann HC1, Hartung HP et al. The Lancet infectious diseases, 2010. PMID:20797646
Glycolipid antigens and autoantibodies in autoimmune neuropathies. Willison HJ, Goodyear CS. Trends in immunology, 2013. PMID:23770405
Intravenous immunoglobulin for Guillain-Barré syndrome. Richard AC Hughes, Anthony V Swan, Pieter A van Doorn. Cochrane Neuromuscular Group, 2014. DOI:10.1002/14651858.CD002063.pub6
Corticosteroids for Guillain-Barré syndrome. Richard AC Hughes, Pieter A van Doorn. Cochrane Neuromuscular Group, 2012. DOI:10.1002/14651858.CD001446.pub4
Pharmacological treatment for pain in Guillain-Barré syndrome. Jia Liu, Lu-Ning Wang, Ewan D McNicol. Cochrane Neuromuscular Group, 2015. DOI:10.1002/14651858.CD009950.pub3
Multidisciplinary care for Guillain-Barré syndrome. Khan F, Ng L et al. Cochrane Neuromuscular Group, 2010. DOI:10.1002/14651858.CD008505.pub2
Health-related quality of life in Guillain-Barré syndrome patients: a systematic review. Darweesh SKL, Polinder S et al. Journal of the Peripheral Nervous System, 2014. DOI:10.1111/jns5.12051
Guillain-Barré syndrome @ NHS Choices. http://www.nhs.uk/conditions/Guillain-Barre-syndrome/Pages/Introduction.aspx
Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. van den Berg B, Walgaard C. Nature reviews. Neurology, 2014. PMID:25023340
Guillain—Barré Syndrome: current understanding, diagnosis, and management of the syndrome. Yuki N, Hartung H-P. NEJM, 2012. DOI:10.1056/NEJMra1114525